Assessing the Potential for Improved Joint Health and Wellbeing by Providing a Whole Salmon Oil With Undenatured Type II Collagen Compared to Type II Collagen Alone

Part of paid clinical trials in San Francisco, California.

Sponsor
Hofseth Biocare ASA
Study ID
NCT07875101
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Joint Discomfort
  • Quality of Life
  • Wellbeing

Eligibility Criteria

Sex
ALL
Age
40 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Undenatured collagen — DIETARY_SUPPLEMENT
    Natural type II collagen
  • Whole salmon oil — DIETARY_SUPPLEMENT
    OmeGo

Study Details

This study evaluates the combination of NT-II® salmon undenatured type II collagen with OmeGo® salmon oil in adults who regularly experience knee discomfort. The aim is to assess whether participants experience faster and greater improvements in joint health with the combination than undenatured type II collagen alone .

Key Dates

First listed
Oct 15, 2026
Start date
Oct 30, 2026
Status verified
Sep 2026
Primary completion
Jan 30, 2027
Completion
Feb 15, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: NT-II 480 + OmeGo®
    Combination arm of undenatured type II collagen and a whole salmon oil
  • Active Comparator: UC-II
    Chicken sternum undenatured type II collagen
  • Experimental: NT-II 240 + OmeGo®
    Combination arm of undenatured type II collagen and a whole salmon oil

Primary Outcome Measure

Change in knee pain measured by visual analogue scale (VAS) score [ Time Frame: From baseline (day 0) to day 5 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Alethios Inc.San FranciscoCalifornia94109
Zoe Benham, MSc
6502068006

Find similar trials in San Francisco, CA

Related Studies